Cameron Turtle, Chief Business Officer at Eidos Therapeutics, Inc. (EIDX), sold 24,791 shares at $70.44 ($1.8M) on 2020-11-02, disclosed to the SEC on 2020-11-03.
Open-market sale of $1.8M EIDX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.44 | 9,145 | $644K | 36.8% |
| 2 | $70.44 | 9,145 | $644K | 36.8% |
| 3 | $71.42 | 3,146 | $225K | 12.8% |
| 4 | $71.42 | 3,146 | $225K | 12.8% |
| 5 | $72.10 | 209 | $15K | 0.9% |
| Total | $70.70 avg | 24,791 |
| $1.8M |
| 100% |
| Filing → |
| SYRE | SELL | 2026-08-05 | $1.4M | — | Filing → |
| SYRE | SELL | 2026-07-02 | $1.3M | — | Filing → |
| SYRE | SELL | 2026-06-03 | $1.1M | — | Filing → |